Inhibiting Mitochondrial Damage for Efficient Treatment of Cerebral Ischemia‐Reperfusion Injury Through Sequential Targeting Nanomedicine of Neuronal Mitochondria in Affected Brain Tissue
Advanced Materials · 2024-12 · 36 (50)
DOI: 10.1002/adma.202409529 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 06.11.2024. Verfasst von Shuya Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, 410008, P. R. China. Hauptthemen laut MEDLINE: Reperfusion Injury, Mitochondria, Nanomedicine, Neurons. Die Arbeit wurde bisher 82-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Innovation-Driven Project of Central South University, Central South University Research Program of Advanced Interdisciplinary Studies.
Abstract (Originalsprache)
Oxidative stress, predominantly from neuronal mitochondrial damage and the resultant cytokine storm, is central to cerebral ischemia‐reperfusion injury (CIRI). However, delivering drugs to neuronal mitochondria remains challenging due to the blood‐brain barrier (BBB), which impedes drug entry into affected brain tissues. This study introduces an innovative tannic acid (TA) and melanin‐modified heteropolyacid nanomedicine (MHT), which highly specifically eliminates the neuronal mitochondrial reactive oxygen radicals burst to efficiently reduce neuronal mitochondrial damage through a strategically designed sequential targeting strategy from affected brain tissue to neuronal mitochondria. TA endows MHT with sequential targeting ability by binding to matrix proteins exposed to the damaged BBB and mitochondrial outer membrane proteins of neurons, while melanin significantly enhances the antioxidant capacity of MHT. Consequently, MHT effectively inhibits neuronal apoptosis by protecting mitochondria and reversing the inflammatory immune environment through the deactivation of the cyclic GMP‐AMP synthase–stimulator of interferon genes (cGAS‐STING) pathway. MHT demonstrated a strong therapeutic effect on CIRI, with an ultralow dose (2 mg kg −1 ) proving effective in reversing the condition. This work not only introduces a new avenue to significantly reduce CIRI through sequential targeting therapy but also offers a new paradigm for treating other ischemia‐reperfusion injury diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, 410008, P. R. China.
- Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410013, P. R. China.
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, P. R. China.
- Geriatric Medical Center, People's Hospital of Ningxia Hui Autonomous Region, Yinchuan, Ningxia, 750002, P. R. China.
- Hunan Provincial Key Laboratory of Cardiovascular Research, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410013, P. R. China.
- Key Laboratory of Aging-related Bone and Joint Diseases Prevention and Treatment, Ministry of Education, Xiangya Hospital, Central South University, Changsha, 410008, P. R. China.
ORCID-Profile: Kelong Ai
Förderung
- National Natural Science Foundation of China
- Innovation-Driven Project of Central South University
- Central South University Research Program of Advanced Interdisciplinary Studies
- Key Research Project of Ningxia Hui Autonomous Region of China
- Key Program of Ningxia Hui Autonomous Region Natural Science Foundation of China
- Key Research and Development Program of Hunan Province of China
Zitieren
APA
Wang, S., Shi, X., Xiong, T., Chen, Q., Yang, Y., Chen, W., Zhang, K., Nan, Y., Huang, Q., & Ai, K. (2024). Inhibiting Mitochondrial Damage for Efficient Treatment of Cerebral Ischemia‐Reperfusion Injury Through Sequential Targeting Nanomedicine of Neuronal Mitochondria in Affected Brain Tissue. Advanced Materials, 36(50). https://doi.org/10.1002/adma.202409529
Vancouver
Wang S, Shi X, Xiong T, Chen Q, Yang Y, Chen W, et al. Inhibiting Mitochondrial Damage for Efficient Treatment of Cerebral Ischemia‐Reperfusion Injury Through Sequential Targeting Nanomedicine of Neuronal Mitochondria in Affected Brain Tissue. Advanced Materials. 2024;36(50). doi:10.1002/adma.202409529
BibTeX
@article{Wang2024,
author = {Wang, Shuya and Shi, Xiaojing and Xiong, Tingli and Chen, Qiaohui and Yang, Yongqi and Chen, Wensheng and Zhang, Kexin and Nan, Yayun and Huang, Qiong and Ai, Kelong},
title = {Inhibiting Mitochondrial Damage for Efficient Treatment of Cerebral Ischemia‐Reperfusion Injury Through Sequential Targeting Nanomedicine of Neuronal Mitochondria in Affected Brain Tissue},
journal = {Advanced Materials},
year = {2024},
volume = {36},
number = {50},
doi = {10.1002/adma.202409529}
}
EUVIMED